MedPath

Feasibility and Safety of Inhaled Heparin in Intubated and Mechanically Ventilated Patients: A Randomized Controlled Trial Comparing Three Doses of Inhaled Unfractionated Heparin.

Conditions
Mechanically ventilated patients without ALI
Registration Number
NL-OMON27158
Lead Sponsor
Academic Medical Centre, Amsterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

1. Patients who are mechanically ventilated;
2. Age > 18 years.

Exclusion Criteria

1. Acute Lung Injury (consensus criteria);
2. Increased risk of bleeding:
a. Within 24 hours after major surgery;
b. Thrombocytes < 50 * 109 / L;
c. PT > 20 sec;
d. APTT > 60 sec;
3. Acute bleeding at any site;
4. Pregnancy or breast feeding.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the curve of serial anti-Xa measurements in plasma.
Secondary Outcome Measures
NameTimeMethod
1. Blood:<br>a. Area under the cure of serial aPTT measurements;<br>b. Whole blood clotting time lung fluid:<br>area under the curve of serial anti-Xa measurements, heparin, factor VII/VIIa, TF, TFPI-antigen, TFPI activity, protein C / activated protein C, prothrombine fragment 1.2, TATc, ETP (Endogenous Thrombin Potential), Fibrin monomers, soluble thrombomodulin, PAPc, PAI;<br>2. Occurrence and severity of bleeding events.
© Copyright 2025. All Rights Reserved by MedPath